Cite
Fujii S, Kikuchi E, Suzuyama H, et al. Structural Development of Salicylanilide-Based SPAK Inhibitors as Candidate Antihypertensive Agents. ChemMedChem. 2021;16(18):2817-2822doi: 10.1002/cmdc.202100273.
Fujii, S., Kikuchi, E., Suzuyama, H., Watanabe, Y., Ishigami-Yuasa, M., Masuno, H., Mori, T., Isobe, K., Uchida, S., & Kagechika, H. (2021). Structural Development of Salicylanilide-Based SPAK Inhibitors as Candidate Antihypertensive Agents. ChemMedChem, 16(18), 2817-2822. https://doi.org/10.1002/cmdc.202100273
Fujii, Shinya, et al. "Structural Development of Salicylanilide-Based SPAK Inhibitors as Candidate Antihypertensive Agents." ChemMedChem vol. 16,18 (2021): 2817-2822. doi: https://doi.org/10.1002/cmdc.202100273
Fujii S, Kikuchi E, Suzuyama H, Watanabe Y, Ishigami-Yuasa M, Masuno H, Mori T, Isobe K, Uchida S, Kagechika H. Structural Development of Salicylanilide-Based SPAK Inhibitors as Candidate Antihypertensive Agents. ChemMedChem. 2021 Sep 16;16(18):2817-2822. doi: 10.1002/cmdc.202100273. Epub 2021 Jul 02. PMID: 34109743.
Copy
Download .nbib